Key result
Recombinant pseudotype baculovirus with T-cell epitopes enhanced IFN-gamma production and neutralizing antibody titers compared to the recombinant without T-cell epitopes in mice.
Answers are grounded in this paper and cite their sources.
A pseudotype baculovirus expressing FMDV capsid protein and a T-cell immunogen enhanced humoral and cellular immune responses in mice, suggesting a potential new vaccine strategy.
BACKGROUND: Foot-and-mouth disease (FMD) is a highly contagious disease of livestock which causes severe economic loss in cloven-hoofed animals. Vaccination is still a major strategy in developing countries to control FMD. Currently, inactivated vaccine of FMDV has been used in many countries with limited success and safety concerns. Development of a novel effective vaccine is must. METHODS: In the present study, two recombinant pseudotype baculoviruses, one expressing the capsid of foot-and-mouth disease virus (FMDV) under the control of a cytomegalovirus immediate early enhancer/promoter (CMV-IE), and the other the caspid plus a T-cell immunogen coding region under a CAG promoter were constructed, and their expression was characterized in mammalian cells. In addition, their immunogenicity in a mouse model was investigated. The humoral and cell-mediated immune responses induced by pseudotype baculovirus were compared with those of inactivated vaccine. RESULTS: Indirect immunofluorescence assay (IFA) and indirect sandwich-ELISA (IS-ELISA) showed both recombinant baculoviruses (with or without T-cell epitopes) were transduced efficiently and expressed target proteins in BHK-21 cells. In mice, intramuscular inoculation of recombinants with 1 × 109 or 1 × 1010 PFU/mouse induced the production of FMDV-specific neutralizing antibodies and gamma interferon (IFN-γ). Furthermore, recombinant baculovirus with T-cell epitopes had better immunogenicity than the recombinant without T-cell epitopes as demonstrated by significantly enhanced IFN-γ production (P < 0.01) and higher neutralizing antibody titer (P < 0.05). Although the inactivated vaccine produced the highest titer of neutralizing antibodies, a lower IFN-γ expression was observed compared to the two recombinant pseudotype baculoviruses. CONCLUSIONS: These results indicate that pseudotype baculovirus-mediated gene delivery could be a alternative strategy to develop a new generation of vaccines against FMDV infection.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2011) studied Foot-and-mouth disease (FMD) vaccination model (n=56). Bac-GED-P12A3CT (recombinant pseudotype baculovirus with T-cell epitopes) vs. Bac-GED-P12A3C (without T-cell epitopes) was evaluated on IFN-gamma production (pg/ml) in splenocytes at 7 weeks (1 × 10^10 PFU dose) (p=<0.01). Recombinant pseudotype baculovirus with T-cell epitopes enhanced IFN-gamma production and neutralizing antibody titers compared to the recombinant without T-cell epitopes in mice.
Synapse has enriched 10 related papers. Consider them for comparative context: